Purchase Short-Term Access
A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone
Mark D. Schleinitz, MD, MS; Paul A. Heidenreich, MD, MS
Annals of Internal Medicine 2005;142:251-259.
doi:10.7326/0003-4819-142-4-200502150-00007
Purchase Online access to this article for 24 hours
